Position in EOLS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$95,841
-$39,938 QoQ
Shares Held
13,810
-32.4% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 158 holders
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PROFUND ADVISORS LLC holds $16,343,377 across 32 Drug Manufacturers - Specialty & Generic names. EOLS ranks #31 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
40,027 | $2,097,414 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
3,432 | $1,859,560 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
10,634 | $1,792,254 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
134,034 | $1,340,340 | |
| 5 | LQDA |
Liquidia Corp
|
7,836 | $624,764 | |
| 6 | ZTS |
Zoetis Inc.
|
7,784 | $559,358 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
13,462 | $552,345 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
22,419 | $551,731 |
All Filings in EOLS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $95,841 | 13,810 | Shares | Sole | 2026-08-11 | |
| 2025-12-31 | $135,779 | 20,418 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $111,262 | 18,121 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $99,771 | 10,833 | Shares | Sole | 2025-08-07 | |
| 2024-12-31 | $142,493 | 12,907 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $130,145 | 11,995 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||